AKT1 and melanoma: More specifically, this Fucoidan, at a concentration of 1 mg/mL, doubles the cell-killing capacity of lapatinib, accompanied by a further reduction in AKT and NFκB signaling, two critical pathways involved in melanoma cell survival [28].